David W. Kaufman, ScD
Director
Boston University Medical Campus
Slone Epidemiology Center

ScD, Harvard University
MS, Harvard University



David W. Kaufman is Professor of Epidemiology at the Boston University School of Public Health and Director of the Slone Epidemiology Center. He obtained his M.S. and Sc.D. in Epidemiology from Harvard School of Public Health. In 1975 he joined the newly created Drug Epidemiology Unit (now the Slone Epidemiology Center ) as a Research Associate. His early career as an epidemiologist at the DEU was primarily spent in studies of drugs and other factors in relation to cancer, heart disease, and various other conditions. Together with Drs. Slone, Shapiro, and Lynn Rosenberg, he participated in the development of Case-Control Surveillance. In the 1980s, Dr. Kaufman was co-investigator of the International Agranulocytosis and Aplastic Anemia Study, a pioneering effort in the evaluation of these extremely rare but often drug-induced blood dyscrasias that was conducted in seven countries with several hundred cases enrolled. He has directed studies of aplastic anemia in Thailand and the United States. The Thai study is the largest epidemiological investigation of aplastic anemia that has been conducted, with over 500 cases and 2200 controls. Dr. Kaufman pursued his interest in rare drug induced diseases as principal investigator of an international study of Stevens-Johnson syndrome and toxic epidermal necrolysis conducted in four countries in Europe, and a study of anaphylaxis conducted in Spain, Hungary, India, and Sweden. Other major activities have included an international study of analgesics in relation to upper gastrointestinal bleeding and the National Analgesic Nephropathy Study, a multicenter study of end stage renal disease patients in three regions of the U.S. Dr. Kaufman worked closely with Allen Mitchell in the implementation of the Slone Survey, a U.S. population-based survey of medication use. He was principal investigator of a recently completed study that documented an inverse relationship between Oxalobacter formigenes, an oxalate metabolizing bacterium found in the colons of about 40% of the normal population, and calcium oxalate kidney stones. He also directed the Patient Registries at Slone: Myeloma and MDS, a recent nationwide effort that followed patients with the two diseases through the course of their illness. Currently Dr. Kaufman is co-principal investigator for a large scale behavioral surveillance program of acetaminophen users and is involved in other postmarketing surveillance activities. He was Assistant Director of the Slone Epidemiology Unit from 1986 to 1997, and was Associate Director from 1998 to 2016.

Professor
Boston University School of Public Health
Epidemiology




Behavioral Surveillance of Acetaminophen Users and Non-Users
03/16/2010 - 01/31/2019 (PI)
McNeill Consumer Healthcare


Evaluation of the Feasibility of a Study of Potential Clinical Sequelae from Brain Hyperintensity Due to Gadolinium-Based Contrast Agents
12/13/2017 - 12/12/2018 (PI)
GE Healthcare, Inc.

Protocol for Development for a Feasibility Study of Thromboembolic Events & Mortality among Users of Beriplex
08/01/2012 - 07/31/2015 (PI)
CSL Behring LLC


Privigen use and haemolytic anaemia in adults and children and the Privigen safety profile in children with CIDP - an observational hospital-based cohort study in the US (Study IGPRO10_5003)
10/22/2014 - 12/31/2014 (PI)
CSL Behring LLC


Sanofi: Pilot study to explore using a physician-based social networking site for enrollment of patients with myeloproliferate neoplasms in quality of life research
09/01/2012 - 02/28/2013 (PI)
Sanofi-Aventis, U.S., LLC


Oxalobacter Formigenes and Other Factors In Urolithiasis
08/01/2003 - 07/31/2007 (PI)
NIH/National Diabetes & Digestive & Kidney Diseases
5 R01 DK62270 03

Herbal Medicine Use in Minority Populations in the U.S.
04/01/2004 - 03/31/2007 (PI)
NIH/Center for Complementary & Alternative Medicine
5 R21 AT02239 02

Cardiovascular Disease Risks of Meloxicam and other NSAIDS
04/06/2005 - 03/31/2006 (PI)
Boehringer Ingelheim Pharmaceuticals, Inc. (Germany)

Consulting Agreement-Pilot Study of Upper GI Bleeding in Japan
07/01/2002 - 06/30/2005 (PI)
Pharmacia Corp

National Analgesic Nephropathy Study
10/15/1999 - 03/31/2004 (PI)
Medical College of Ohio NIH NIDDK

Showing 10 of 15 results. Show All Results



Yr Title Project-Sub Proj Pubs
2005 Herbal Medicine Use in Minority Populations in the US 5R21AT002239-02 1
2005 Oxalobacter Formigenes and Other Factors in Urolithiasis 5R01DK062270-03 4
2004 Herbal Medicine Use in Minority Populations in the US 1R21AT002239-01 1
2004 Oxalobacter Formigenes and Other Factors in Urolithiasis 5R01DK062270-02 4
2003 Oxalobacter Formigenes and Other Factors in Urolithiasis 1R01DK062270-01A1 4
2000 APLASTIC ANEMIA EPIDEMIOLOGY--INCIDENCE AND CASE CONTROL 5R01HL035068-09 14
1999 APLASTIC ANEMIA EPIDEMIOLOGY--INCIDENCE AND CASE CONTROL 5R01HL035068-08 14
1998 APLASTIC ANEMIA EPIDEMIOLOGY--INCIDENCE AND CASE CONTROL 2R01HL035068-07A1 14
1995 DATA FROM TWO STUDIES OF BLOOD DYSCRASIAS 5R03HL052351-02
1995 ANALGESIC AND NSAID USE AND GASTROINTESTINAL BLEEDING 5R01DK036997-08 6
Showing 10 of 24 results. Show All Results
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Shiffman S, Battista DR, Kelly JP, Malone MK, Weinstein RB, Kaufman DW. Prevalence of exceeding maximum daily dose of paracetamol, and seasonal variations in cold-flu season. Br J Clin Pharmacol. 2018 Mar 07. PMID: 29516533.
     
  2. Kaufman DW, Kelly JP, Battista DR, Malone MK, Weinstein RB, Shiffman S. Exceeding the daily dosing limit of nonsteroidal anti-inflammatory drugs among ibuprofen users. Pharmacoepidemiol Drug Saf. 2018 Mar; 27(3):322-331. PMID: 29372579.
     
  3. Borgatta L, Kaufman D, Kelly JP, Babaian D, Banks M. Applications for Research Concerning Fetal or Placental Tissue and Expected Institutional Review Board Responses. J Empir Res Hum Res Ethics. 2017 Jul; 12(3):150-160. PMID: 28535711.
     
  4. Ernst FR, Pocoski J, Cutter G, Kaufman DW, Pleimes D. Analysis of Diagnoses Associated with Multiple Sclerosis-Related In-Hospital Mortality Using the Premier Hospital Database. Int J MS Care. 2016 May-Jun; 18(3):154-61. PMID: 27252603; DOI: 10.7224/1537-2073.2014-109;.
     
  5. Public Policy Committee, International Society of Pharmacoepidemiology. Guidelines for good pharmacoepidemiology practice (GPP). Pharmacoepidemiol Drug Saf. 2016; 25:2-10. View Publication
     
  6. Kaufman DW, Kelly JP, Battista DR, Malone MK, Weinstein RB, Shiffman S. Relation of Health Literacy to Exceeding the Labeled Maximum Daily Dose of Acetaminophen. Am J Prev Med. 2016 Jun; 50(6):e183-e190. PMID: 26689980; DOI: 10.1016/j.amepre.2015.11.005;.
     
  7. Shiffman S, Rohay JM, Battista D, Kelly JP, Malone MK, Weinstein RB, Kaufman DW. Patterns of acetaminophen medication use associated with exceeding the recommended maximum daily dose. Pharmacoepidemiol Drug Saf. 2015 Sep; 24(9):915-21. PMID: 26149538; DOI: 10.1002/pds.3830;.
     
  8. Goodin DS, Corwin M, Kaufman D, Golub H, Reshef S, Rametta MJ, Knappertz V, Cutter G, Pleimes D. Causes of death among commercially insured multiple sclerosis patients in the United States. PLoS One. 2014; 9(8):e105207.View Related Profiles. PMID: 25144226; PMCID: PMC4140735; DOI: 10.1371/journal.pone.0105207;.
     
  9. Kaufman DW, Reshef S, Golub HL, Peucker M, Corwin MJ, Goodin DS, Knappertz V, Pleimes D, Cutter G. Survival in commercially insured multiple sclerosis patients and comparator subjects in the U.S. Mult Scler Relat Disord. 2014 May; 3(3):364-71.View Related Profiles. PMID: 25876474; DOI: 10.1016/j.msard.2013.12.003;.
     
  10. Kaufman DW. Textbook of pharmacoepidemiology (Strom BL, Kimmel SE, Hennessy S, eds.). Field Studies. Wiley-Blackwell. West Sussex. 2013; 178-189.
     
Showing 10 of 162 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 153 publications over 38 distinct years, with a maximum of 11 publications in 1980

YearPublications
198011
19813
19825
19836
19845
19858
19865
19876
19885
19897
19903
19915
19923
19934
19941
19954
19964
19978
19982
19995
20002
20013
20023
20032
20054
20065
20072
20088
20095
20102
20115
20122
20132
20141
20152
20162
20171
20182
Contact for Mentoring:


72 E. Concord St Instructional (L)
Boston MA 02118
Google Map


Kaufman's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department